As body weight decreases, patients may experience better energy, improved confidence, reduced strain on joints, and better control of weight-related health concerns
The class consists of several synthetic subcutaneously administered GLP-1 analogues such as shorter acting exenatide, liraglutide, lixisenatide, longer acting dulaglutide, albiglutide, efpeglenatide and semaglutide and a dual GIP/GLP-1 agonist tirzepatide (106)
But retatrutide adds a third target: the glucagon receptor
RELATED: Will I Regain Weight After StoppingPrescription Weight Loss Medications
Utracisz dostp do tytuw z katalogu z nieograniczonym dostpem, a take do wszystkich tytuw wybranych w ramach comiesicznego wyboru z subskrypcj Audible Standard
Furthermore, a doctor must assess your BMI and full medical history to confirm you arent at risk for specific contraindications